Conn. Jumps Into Zyprexa Fray With Lawsuit
Echoing allegations that Eli Lilly already faces in a massive multidistrict litigation in the Eastern District of New York, Connecticut alleges that Eli Lilly first overcharged for the drug and then marketed it through a fraudulent campaign that concealed its possible link to diabetes.
The lawsuit also alleges that the company engaged in racketeering with medical marketing firms and doctors in...
To view the full article, register now.